Bob Durkin and Richard Oparil Quoted in an Article by PharmaIntelligence Titled “Amazon’s VMS Policy Mirrors US FDA Rules But May Reflect Stronger Industry Compliance”

AGG partner Richard J. Oparil and of counsel Robert Durkin was quoted in a PharmaIntelligence article, titled “Amazon’s VMS Policy Mirrors US FDA Rules But May Reflect Stronger Industry Compliance,” on January 12, 2021.

For more information or to view the full article, please click here.